Shape-Dependent Skin Penetration of Silver Nanoparticles: Does It Really Matter?

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tak, Yu Kyung ^a   Pal, Sukdeb ^b   Naoghare, Pravin K ^b   Rangasamy, Sabarinathan ^a   Song, Joon Myong ^a  

^a Seoul National University   (South Korea)

^b NATIONAL ENVIRONMENTAL ENGINEERING RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METAL NANOPARTICLE; SILVER;

ALGORITHM; ANIMAL; CHEMISTRY; DIFFUSION; ELECTRIC CONDUCTIVITY; HAIRLESS MOUSE; MALE; MASS SPECTROMETRY; METABOLISM; PARTICLE SIZE; PERMEABILITY; PROCEDURES; SKIN; SKIN ABSORPTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ALGORITHMS; ANIMALS; ANTI-BACTERIAL AGENTS; DIFFUSION; ELECTRIC CONDUCTIVITY; MALE; MASS SPECTROMETRY; METAL NANOPARTICLES; MICE, HAIRLESS; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; PERMEABILITY; SILVER; SKIN; SKIN ABSORPTION;

EID: 84947579486     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16908     Document Type: Article

References (28)

1. Pal, S., Yoon, E. J., Tak, Y. K., Choi, E. C., Song, J. M. Synthesis of highly antibacterial nanocrystalline trivalent silver polydiguanide. J. Am. Chem. Soc. 131, 16147-16155 (2009).
2. Pal, S., Yoon, E. J., Park, S. H., Choi, E. C.& Song, J. M. Metallopharmaceuticals based on silver(I) and silver(II) polydiguanide complexes-Activity against burn wound pathogens. J. Antimicrob. Chemother. 65, 2134-2140 (2010).
3. Elechiguerra, J. L. et al. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 3, 6 (2005).
4. Morones, J. R. et al. The bactericidal effect of silver nanoparticles. Nanotechnology 16, 2346-2353 (2005).
5. Pal, S., Tak, Y. K., Song, J. M. Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle A Study of the Gram-Negative Bacterium Escherichia coli. Appl. Environ. Microbiol. 73, 1712-1720 (2007).
6. Schneider, M., Stracke, F., Hansen, S., Schaefer, U. F. Nanoparticles and their interactions with the dermal barrier. Derm.-Endocrinol. 1, 197-206 (2009).
7. Sykes, E. A., Dai, Q., Tsoi, K. M., Hwang, D. M., Chan, W. C. Nanoparticle exposure in animals can be visualized in the skin and analysed via skin biopsy. Nat Commun. 13, 3796 (2014).
8. Chilcott, R. P. Cutaneous Anatomy and Function, in Principles and Practice of Skin Toxicology 1-16 (John Wiley & Sons, Ltd, 2008).
9. Watkinson, A. C., Bunge, A. L., Hadgraft, J., Lane, M. E. Nanoparticles do not penetrate human skin-a theoretical perspective. Pharm. Res. 30, 1943-1946 (2013).
10. Larese, F., Gianpietro, A., Venier, M., Maina, G., Renzi, N. In vitro percutaneous absorption of metal compounds. Toxicol. Lett. 170, 49-56 (2007).
11. R. C. Scott & R. H. G., Jonathan Hadgraft Prediction of Percutaneous Penetration. (London, IBC Technical Services, 1990).
12. Honeywell-Nguyen, P. L., Bouwstra, J. A. Vesicles as a tool for transdermal and dermal delivery. Drug. Discov. Today. Technol. 2, 67-74 (2005).
13. Eastman, J., Stability of charged colloids, in: T. Cosgrove (Ed.), Colloid science: principles, methods and applications, Blackwell publishing, United Kingdom, 2005, p.54.
14. Alvarez-Román, R., Naik, A., Kalia, Y. N., Guy, R. H., Fessi, H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Release. 99, 53-62 (2004).
15. Liu, H. et al. Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew. Chem. Int. Ed. Engl. 4, 891-895 (2011).
16. Elias, P. The skin barrier as an innate immune element. Semin. Immunopathol. 29, 3-14 (2007).
17. Wang, Q. et al. Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nat Commun. 4, 1867 (2013).
18. Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., Fuchs, H. Nanomedicine-challenge and perspectives. Angew. Chem. Int. Ed. Engl. 5, 872-897 (2009).
19. "EPA Reference Dose for Silver", http://www.silverhealthinstitute.com/epa-reference-dose-for-silver/. Accessed August 01, 2015.
20. Panyala, N., Pena-Mendez, E., Havel, J. Silver or silver nanoparticles: a hazardous threat to the environment and human health J. Appl. Biomed. 6, 117-129 (2008).
21. Kim, Y. S. et al. Subchronic oral toxicity of silver nanoparticles. Part. Fibre. Toxicol. 7, 20 (2010).
22. Li, N., Zhao, P., Astruc, D. Anisotropic Gold Nanoparticles: Synthesis, Properties, Applications, and Toxicity Angew. Chem. Int. Ed. Engl. 53, 1756-1789 (2014).
23. Swami, A., Shi, J., Gadde, S., Votruba, A. R., Kolishetti, N., Faraokhzad, O. C. Nanoparticles for targeted and temporally controlled drug delivery. S. Svenson & R. K. Prud'homme (eds.), Multifunctional Nanoparticles for Drug Delivery Applications: Imaging, Targeting, and Delivery, Nanostructure Science and Technology. doi: 10.1007/978-1-4614-2305-8-2.
24. Sarin, H. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J. Angiog. Res. 2, 1-19 (2010).
25. Asghari, S. et al. Toxicity of various silver nanoparticles compared to silver ions in Daphnia magna. J. Nanobiotechnol. 10, 14 (2012).
26. DiVincenzo, G. D., Giordano, C. J., Schriever, L. S. Biologic monitoring of workers exposed to silver. Int. Arch. Occup. Environ. Health. 56, 207-215 (1985).
27. Sadeghi, B. et al. Comparison of the anti-bacterial activity on the nanosilver shapes: Nanoparticles, nanorods and nanoplates. Adv. Powder Technol. 23, 22-26 (2012).
28. Zhou, Y., Kong, Y., Kundu, S., Cirillo, J., Liang, H. Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guerin. J. Nanobiotechnol. 10, 19 (2012).